| Iron in neurodegeneration–cause or consequence? A Ndayisaba, C Kaindlstorfer, GK Wenning Frontiers in neuroscience 13, 180, 2019 | 246 | 2019 |
| Decrease in mortality of adult epilepsy patients since 1980: lessons learned from a hospital-based cohort C Granbichler, W Oberaigner, G Kuchukhidze, JP Ndayisaba, ... Eur J Neurol 24 (5), 667-672, 2017 | 20 | 2017 |
| TNFα inhibitors as targets for protective therapies in MSA: a viewpoint A Ndayisaba, K Jellinger, T Berger, GK Wenning Journal of Neuroinflammation 16, 1-7, 2019 | 14 | 2019 |
| Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype of α-synuclein inclusions I Lam#, A Ndayisaba#, AJ Lewis, YH Fu, GT Sagredo, L Zaccagnini, ... bioRxiv, 2022.11. 08.515615, 2022 | 5 | 2022 |
| GK Wenning Iron in Neurodegeneration–Cause or Consequence?., 2019, 13 A Ndayisaba, C Kaindlstorfer DOI: https://doi. org/10.3389/fnins, 180, 2019 | 5 | 2019 |
| Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy A Ndayisaba, GK Wenning Clinical Autonomic Research 30, 7-8, 2020 | 4 | 2020 |
| Toward the quantification of α-synuclein aggregates with digital seed amplification assays T Gilboa, Z Swank, R Thakur, RA Gould, KH Ooi, M Norman, EA Flynn, ... Proceedings of the National Academy of Sciences 121 (3), e2312031121, 2024 | 3 | 2024 |
| Genome sequence analyses identify novel risk loci for multiple system atrophy R Chia, A Ray, Z Shah, J Ding, P Ruffo, M Fujita, V Menon, ... Neuron, 2024 | 2 | 2024 |
| Sequential CRISPR screening reveals partial NatB inhibition as a strategy to mitigate alpha-synuclein levels in human neurons S Santhosh Kumar, NN Naseri, SR Pather, E Hallacli, A Ndayisaba, ... Science Advances 10 (6), eadj4767, 2024 | 2 | 2024 |
| Clinical Trial-Ready Patient Cohorts for Multiple System Atrophy: Coupling Biospecimen and iPSC Banking to Longitudinal Deep-Phenotyping A Ndayisaba#, AT Pitaro#, AS Willett#, KA Jones, CM de Gusmao, ... The Cerebellum, 1-21, 2022 | 2 | 2022 |
| Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges A Ndayisaba, M Herrera-Vaquero, GK Wenning, N Stefanova Clinical Autonomic Research 29, 385-395, 2019 | 2 | 2019 |
| Suggested searches TW McDade, J Rockström, L Kotzé, S Milutinović, F Biermann, V Brovkin, ... Perspective, 2024 | | 2024 |
| Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping A Ndayisaba#, AT Pitaro#, AS Willett#, KA Jones, CM de Gusmao, ... The Cerebellum, 1-2, 2022 | | 2022 |
| Rapid iPSC inclusionopathy models shed light on formation, consequence and molecular subtype I Lam#, A Ndayisaba#, AJ Lewis, YH Fu, GT Sagredo transgene 20, 40, 0 | | |
